Atrial Fibrillation and Gout Epidemiology Reports - 2023 Forecasts in New Market Research Reports

DALLAS, May 7, 2014 /PRNewswire/ --

LifeScienceIndustryResearch.com offers "EpiCast Report: Gout - Epidemiology Forecast to 2023" and "EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023" market research reports in its store.

In EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023 report, epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023. Epidemiologists attribute the growth in the diagnosed prevalent cases of AF in the 8MM to the changing population demographics in the respective markets, rather than an actual increase in the diagnosed prevalence of AF in these markets. Complete report is available at http://www.lifescienceindustryresearch.com/epicast-report-atrial-fibrillation-epidemiology-forecast-to-2023.html .

EpiCast Report: Gout - Epidemiology Forecast to 2023 report forecasts an increase in both the diagnosed incident cases and diagnosed prevalent cases of gout in the 6MM, from 1,374,065 diagnosed incident cases in 2013 to 1,649,065 diagnosed incident cases in 2023, at an annual growth rate (AGR) of 2.00%, and 13,750,047 diagnosed prevalent cases in 2013 to 17,625,944 diagnosed prevalent cases in 2023, at an AGR of 2.82%. Complete report is available at http://www.lifescienceindustryresearch.com/epicast-report-gout-epidemiology-forecast-to-2023.html .

This gout market forecast is supported by ageand sex-specific data obtained from country-specific estimates from peer reviewed journal articles, in which the study populations were representative of the general population in the respective markets. Epidemiologists used historical diagnosed incidence and diagnosed prevalence data which were available for Italy and the UK, along with linear regression methods to forecast the ageand sex-specific diagnosed incidence and diagnosed prevalence for Italy and the UK through 2023. The forecast provides the ageand sex-specific diagnosed incident cases and diagnosed prevalent cases of gout in each of the 6MM, with clinically relevant segmentations, which facilitate an in depth understanding of the emerging temporal trends, and informs strategies to improve the management of the disease. Additionally, epidemiologists used the same methodology across the 6MM, which allows for a meaningful comparison of the forecast diagnosed incident cases and diagnosed prevalent cases of gout across these markets. Order a copy of EpiCast Report: Gout - Epidemiology Forecast to 2023 market research report at http://www.lifescienceindustryresearch.com/purchase?rname=10769 .

Atrial fibrillation (AF) is a disorder of the heart's electrical system. AF is one of the most common cardiovascular diseases among the elderly, worldwide. According to the Global Burden of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world's population, in 2010, of which 20.9 million were men and 12.6 million were women. The disease burden is likely to increase in the near future due to the projected increase in the population, especially the elderly population. Scope of EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023 market research report covers:

• The Atrial fibrillation (AF) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of AF in the 8MM (US, France, Germany, Italy, Spain, UK, Japan and Canada). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of AF segmented by age (ages =40 years), sex, and clinical subtypes (paroxysmal, persistent, and permanent AF) in these markets.
• The AF epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
• The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Order a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=10770 .

Here are a couple of other new reports on pharmaceuticals available with Life Science Industry Research:

The Cancer Vaccine Partnering Terms and Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by…. Complete report is available at http://www.lifescienceindustryresearch.com/cancer-vaccine-partnering-terms-and-agreements.html .

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world's biopharma companies. his report contains a comprehensive listing of all manufacturing and supply deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Complete report is available at http://www.lifescienceindustryresearch.com/manufacturing-and-supply-partnering-terms-and-agreements-in-pharma-biotech-and-diagnostics.html .

Explore more reports on the pharmaceuticals industry at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us: 

Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.

Contact us (sales@lifescienceindustryresearch.com / + 1 888 391 5441) for any of your research requirements or topics of interest. Our sales & research associates will be happy to help you find relevant market data.

Contact: 

Priyank Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
sales@lifescienceindustryresearch.com

http://www.lifescienceindustryresearch.com/lifescience-news

Connect With Us on: 

Facebook: https://www.facebook.com/lifescienceindustryresearch

Twitter: https://twitter.com/LifeSciReports

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

RSS Feeds: http://www.lifescienceindustryresearch.com/feed

SOURCE LifeScienceIndustryResearch.com